title: DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance?
abstract: Targeting of antigens to the endocytic uptake receptor DEC205 resulted in enhanced antigen presentation by dendritic cells (DCs). In combination with adjuvants for DC maturation, proteins coupled to an antibody against DEC205 induced strong pathogen-specific immune responses, whereas without additional adjuvant tolerance could be induced. As less is known about DNA vaccines encoding DEC205-targeted antigens, we explored the immunogenicity and efficacy of a dendritic cell-targeted DNA vaccine against influenza A virus (IAV) delivered by electroporation. Although coupling of haemagglutinin to a single-chain antibody against DEC205 enhanced antigen presentation on MHC class II and activation of T-cell receptor-transgenic CD4 T cells, the T-cell responses induced by the targeted DNA vaccine in wild-type BALB/c mice were significantly reduced compared with DNA encoding non-targeted antigens. Consistently, these mice were less protected against an IAV infection. Adoptive transfer experiments were performed to assess the fate of the antigen-specific T cells in animals vaccinated with DNA encoding DEC205-targeted antigens. By this, we could exclude the general deletion of antigen-specific T cells as cause for the reduced efficacy, but observed a local expansion of antigen-specific regulatory T cells, which could suppress the activation of effector cells. In conclusion, DNA vaccines encoding DEC205-targeted antigens induce peripheral tolerance rather than immunity in our study. Finally, we evaluated our DNA vaccines as prophylactic or therapeutic treatment in an allergen-induced asthma mouse model.
authors.affiliation: Department of Molecular and Medical Virology, Ruhr-University, Bochum, Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Niezold
authors.affiliation: Department of Molecular and Medical Virology, Ruhr-University, Bochum, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Storcksdieck Genannt Bonsmann
authors.affiliation: Department of Molecular and Medical Virology, Ruhr-University, Bochum, Germany.
authors.forename: André
authors.initials: A
authors.lastname: Maaske
authors.affiliation: Department of Molecular and Medical Virology, Ruhr-University, Bochum, Germany.
authors.forename: Vladimir
authors.initials: V
authors.lastname: Temchura
authors.affiliation: Department of Molecular and Medical Virology, Ruhr-University, Bochum, Germany.
authors.forename: Vanessa
authors.initials: V
authors.lastname: Heinecke
authors.affiliation: Ichor Medical Systems Inc., San Diego, CA, USA.
authors.forename: Drew
authors.initials: D
authors.lastname: Hannaman
authors.affiliation: Institute of Medical Microbiology University Hospital, Essen.
authors.forename: Jan
authors.initials: J
authors.lastname: Buer
authors.affiliation: Institute of Molecular Virology, Centre for Molecular Biology of Inflammation, University of Münster, Münster.
authors.forename: Christina
authors.initials: C
authors.lastname: Ehrhardt
authors.affiliation: Institute of Medical Microbiology University Hospital, Essen.
authors.forename: Wiebke
authors.initials: W
authors.lastname: Hansen
authors.affiliation: Department of Molecular and Medical Virology, Ruhr-University, Bochum, Germany.|Universitätsklinikum Erlangen, Institute of Clinical and Medical Virology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
authors.forename: Klaus
authors.initials: K
authors.lastname: Überla
authors.affiliation: Department of Molecular and Medical Virology, Ruhr-University, Bochum, Germany.
authors.forename: Matthias
authors.initials: M
authors.lastname: Tenbusch
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000276:immunology*; D000956:Antigens, Viral / Q000235:genetics / Q000276:immunology / Q000494:pharmacology; D001249:Asthma / Q000276:immunology / Q000517:prevention & control; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D057809:HEK293 Cells; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D007111:Immunity, Cellular / Q000187:drug effects*; D009980:Influenza A virus / Q000235:genetics / Q000276:immunology*; D007252:Influenza Vaccines / Q000235:genetics / Q000276:immunology / Q000494:pharmacology*; D037181:Lectins, C-Type / Q000276:immunology*; D051379:Mice; D015778:Minor Histocompatibility Antigens; D009976:Orthomyxoviridae Infections / Q000276:immunology* / Q000517:prevention & control; D011956:Receptors, Cell Surface / Q000276:immunology*; D019444:Vaccines, DNA / Q000235:genetics / Q000276:immunology / Q000494:pharmacology*
chemical_list: D015703:Antigens, CD; D000956:Antigens, Viral; C093569:DEC-205 receptor; D000949:Histocompatibility Antigens Class II; D007252:Influenza Vaccines; D037181:Lectins, C-Type; D015778:Minor Histocompatibility Antigens; D011956:Receptors, Cell Surface; D019444:Vaccines, DNA
keywords: DNA vaccine; dendritic cells; immune response; tolerance
references.citation: Nat Immunol. 2001 Mar;2(3):261-8
references.pmid: 11224527
references.citation: Immunity. 2004 Jun;20(6):695-705
references.pmid: 15189735
references.citation: Vaccine. 2002 May 15;20(16):2045-52
references.pmid: 11972972
references.citation: Nature. 1998 Mar 19;392(6673):245-52
references.pmid: 9521319
references.citation: J Immunol. 1998 Jan 1;160(1):322-7
references.pmid: 9551987
references.citation: J Virol. 1998 Jul;72(7):5648-53
references.pmid: 9621023
references.citation: J Interferon Cytokine Res. 1998 Jul;18(7):537-47
references.pmid: 9712370
references.citation: J Immunol. 1999 Apr 1;162(7):4163-70
references.pmid: 10201942
references.citation: Clin Exp Allergy. 2005 Aug;35(8):1003-13
references.pmid: 16120081
references.citation: Nat Immunol. 2005 Dec;6(12):1219-27
references.pmid: 16244650
references.citation: Thorax. 2006 Feb;61(2):134-9
references.pmid: 16244088
references.citation: J Exp Med. 2006 Mar 20;203(3):599-606
references.pmid: 16505139
references.citation: J Exp Med. 2006 Mar 20;203(3):607-17
references.pmid: 16505141
references.citation: Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):546-50
references.pmid: 16700892
references.citation: Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1243-50
references.pmid: 17001101
references.citation: J Immunol. 2006 Dec 15;177(12):8410-21
references.pmid: 17142738
references.citation: Science. 2007 Jan 5;315(5808):107-11
references.pmid: 17204652
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1289-94
references.pmid: 17229838
references.citation: J Exp Med. 2007 May 14;204(5):1095-106
references.pmid: 17438065
references.citation: BMC Immunol. 2013;14:39
references.pmid: 23941509
references.citation: PLoS One. 2013;8(8):e72217
references.pmid: 23967287
references.citation: Science. 1990 Mar 23;247(4949 Pt 1):1465-8
references.pmid: 1690918
references.citation: Science. 1993 Mar 19;259(5102):1745-9
references.pmid: 8456302
references.citation: Vaccine. 1993;11(9):957-60
references.pmid: 8212843
references.citation: Science. 1994 Feb 25;263(5150):1139-43
references.pmid: 7509084
references.citation: J Exp Med. 1994 Jul 1;180(1):25-34
references.pmid: 8006585
references.citation: Nature. 1995 May 11;375(6527):151-5
references.pmid: 7753172
references.citation: Nat Med. 1995 Jun;1(6):583-7
references.pmid: 7585127
references.citation: J Immunol. 1996 Aug 1;157(3):978-83
references.pmid: 8757600
references.citation: J Exp Med. 1996 Aug 1;184(2):387-96
references.pmid: 8760792
references.citation: J Exp Med. 2001 Sep 17;194(6):769-79
references.pmid: 11560993
references.citation: Nature. 2007 Sep 27;449(7161):419-26
references.pmid: 17898760
references.citation: J Immunol Methods. 2008 Feb 29;331(1-2):27-38
references.pmid: 18054954
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2574-9
references.pmid: 18256187
references.citation: J Clin Invest. 2008 Apr;118(4):1427-36
references.pmid: 18324335
references.citation: Blood. 2008 Aug 15;112(4):1231-9
references.pmid: 18519810
references.citation: J Exp Med. 2004 Mar 15;199(6):815-24
references.pmid: 15024047
references.citation: J Biotechnol. 2004 May 13;110(1):1-10
references.pmid: 15099900
references.citation: Intervirology. 2008;51(4):241-6
references.pmid: 18812697
references.citation: J Immunol. 2009 Jul 1;183(1):181-90
references.pmid: 19542429
references.citation: Ann N Y Acad Sci. 2009 Sep;1174:6-17
references.pmid: 19769731
references.citation: J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S306-13
references.pmid: 20176266
references.citation: Vaccine. 2010 Apr 26;28(19):3273-7
references.pmid: 20206668
references.citation: Blood. 2010 Sep 30;116(13):2277-85
references.pmid: 20566893
references.citation: Curr Opin Immunol. 2011 Jun;23(3):421-9
references.pmid: 21530212
references.citation: Exp Dermatol. 2012 May;21(5):395-8
references.pmid: 22509840
references.citation: PLoS One. 2012;7(6):e39038
references.pmid: 22720025
references.citation: Int Immunol. 2013 Apr;25(4):247-58
references.pmid: 23184617
references.citation: J Immunol. 2013 Sep 15;191(6):2938-47
references.pmid: 23945139
references.citation: Eur J Immunol. 2013 Oct;43(10):2554-65
references.pmid: 23836147
references.citation: Nat Rev Genet. 2008 Oct;9(10):776-88
references.pmid: 18781156
references.citation: Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8427-32
references.pmid: 10890924
references.citation: J Cell Biol. 2000 Oct 30;151(3):673-84
references.pmid: 11062267
references.citation: J Virol. 2000 Dec;74(24):11598-607
references.pmid: 11090158
references.citation: J Leukoc Biol. 2000 Dec;68(6):793-806
references.pmid: 11129646
references.citation: Vaccine. 2001 Feb 8;19(13-14):1688-93
references.pmid: 11166892
references.citation: Vaccine. 2002 Sep 10;20(27-28):3399-3408
references.pmid: 12213410
references.citation: J Exp Med. 2002 Dec 16;196(12):1627-38
references.pmid: 12486105
references.citation: Blood. 2003 Jun 15;101(12):4862-9
references.pmid: 12543858
references.citation: Immunity. 1997 Apr;6(4):411-7
references.pmid: 9133420